Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

Saved in:
Bibliographic Details
Title: Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Authors: Deanfield J; Institute of Cardiovascular Sciences, University College London, London, UK. Electronic address: john.e.deanfield@gmail.com., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Scirica BM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kahn SE; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Ryan D; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Colhoun HM; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA., Hovingh GK; Novo Nordisk, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands., Hardt-Lindberg S; Novo Nordisk, Søborg, Denmark., Frenkel O; Novo Nordisk, Søborg, Denmark., Weeke PE; Novo Nordisk, Søborg, Denmark., Rasmussen S; Novo Nordisk, Søborg, Denmark., Goudev A; Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria., Lang CC; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK., Urina-Triana M; Faculty of Health Sciences, Universidad Simón Bolívar, Barranquilla, Colombia., Pietilä M; Heart Center, Turku University Hospital, University of Turku, Turku, Finland., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Corporate Authors: SELECT Trial Investigators
Source: Lancet (London, England) [Lancet] 2024 Aug 24; Vol. 404 (10454), pp. 773-786.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(24)01498-3